NASDAQ:GRTS

Gritstone Oncology Earning Date

USA |NASDAQ |USD

GRTS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 5, 2021 Sep 2021 $-0.52 $-0.33 $-0.69
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 5, 2021 Sep 2021 $2.24M $2.84M $939.00K

Gritstone Oncology's next earnings date is Friday, Nov 5, 2021 for the fiscal quarter ending Sep 2021.

GRTS Earnings Date & History Chart

GRTS Earnings & Revenue Forecast

GRTS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.52 $-0.72 $-0.34
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.25 $-1.54 $-0.96
Dec 2022 4 $-2.16 $-3.93 $-1.19

GRTS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.54 $-0.55 $-0.58
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-1.27 $-1.33 $-1.53
Dec 2022 1 / 0 $-2.22 $-2.22 $-2.44

GRTS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $2.24M $1.00M $3.25M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $47.01M $44.54M $49.04M
Dec 2022 4 $24.18M $5.00M $68.00M

GRTS Earnings Date & Revenue History

GRTS Earnings History

|
Show More
Show More

GRTS Revenue History

|
Show More
Show More

Gritstone Oncology Next Earnings Date & Report

GRTS Next Earnings Date & Report Preview: Sep 2021 (FQ)

GRTS's next earnings date is Friday, Nov 5, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Gritstone Oncology's next quarterly earnings is $-0.52, with a low EPS estimation of $-0.66, and a high estimation of $-0.38.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.53, the last 2 month trend is $-0.54, and the 3 month trend is $-0.59.

Based on 4 analysts, the average revenue estimation is $2.24M, with a low revenue estimation of $1.00M, and a high estimation of $3.25M.

Gritstone Oncology Previous Earnings Dates & Reports

GRTS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Gritstone Oncology's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

GRTS's earnings per share (EPS) was $-0.33, beating the consensus analysts forecast of $-0.62 by 46.34%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -430.00%, and higher than the same period a year before (Jun 2020) by -52.17%.

Revenues were $2.84M, better than the forecast of $2.24M by 26.92%, down by -92.84% from the previous quarter , and up by 482.58% from the same period last year.

The company reported a net income of $-25.12M.

Free cash flow for the quarter was $-24.35M , compared to $9.66M last quarter and $-21.75M a year before.

GRTS ended the quarter with $22.35M in total debt, a decrease of -5.68% compared to the previous quarter, and a decrease of -15.67% compared to the same quarter a year before.

GRTS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Gritstone Oncology's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

GRTS's earnings per share (EPS) was $-2.78, missing the consensus analysts forecast of $-2.68 by 3.73% , and higher than the previous year's EPS (Dec 2019) by -0.36%.

Revenues were $4.04M, better than the forecast of $3.89M by 3.78%, and down by -7.51% from previous year's revenue.

The company reported a net income of $-105.31M.

Gritstone Oncology reported a free cash flow of $-92.62M for its fiscal year, compared to $-101.18M a year ago.

The company ended the fiscal year with $25.10M in total debt, an increase of 6.85% compared to the previous year.